ATXS logo

Astria Therapeutics, Inc. (ATXS)

Profile

Full Name

Astria Therapeutics, Inc.

Ticker

NASDAQ: ATXS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 25, 2015

Indexes

Not included

Website

https://www.astriatx.com

Employees

78

Key Details

Price

$7.52(+7.43%)

Market cap

$424.39M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.68(+30.58% YoY)

PE ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.52
    ATXS price is $7.52

    30-Day Relative Volume

    1.97
    ATXS 30-day relative volume is 1.97

    Price Performance

    Price Most recent change

    +7.43%
    ATXS price was up +7.43% on Sep 5, 2025

    Price YTD change

    -15.88%
    ATXS price is down -15.88% since January 1st

    Price 1-year change

    -32.37%
    ATXS price is down -32.37% year-on-year

    Price 3-year change

    -20.42%
    ATXS price is down -20.42% over the past 3 years

    Price Range

    Price All-time high

    $1017.60
    ATXS price is currently -99.26% below its historical high of $1017.60

    Price 3-year low

    $3.56
    ATXS price is currently +111.53% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $424.39M
    ATXS market capitalization is $424.39 million

    Market cap 3-year change

    +245%
    ATXS market capitalization is up +245% over the past 3 years

    Market cap All-time high

    $916.33M
    ATXS market capitalization is currently -53.69% below its historical high of $916.33 million

    Market cap sector rank

    61.71%
    ATXS market capitalization is higher than 61.71% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.02%
    ATXS shares outstanding is up +0.02% year-on-year

    Shares Outstanding 3-Year Change

    +333.55%
    ATXS shares outstanding is up +333.55% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.33
    ATXS beta is 1.33

    200-day SMA

    $6.65
    ATXS price is currently +13.10% above its 200-day simple moving average

    50-day SMA

    $6.48
    ATXS price is currently +16.09% above its 50-day simple moving average

    RSI

    64.10
    ATXS 14-day relative strength index is 64.10

    Volume

    1.97
    ATXS 30-day relative volume is 1.97

    ATR

    $0.45
    ATXS average true range is $0.45

    10-day Historical Volatility

    80.32%
    ATXS 10-day historical volatility is 80.32%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ATXS annual revenue is $0.00

    Revenue Analysts estimate

    $13.67M
    ATXS annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    0%
    ATXS annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    ATXS annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$1.68
    ATXS annual earnings per share is -$1.68

    EPS Analysts estimate

    -$2.14
    ATXS annual earnings per share is currently -21.56% lower than the consensus analysts' forecast

    EPS 1-year change

    +30.58%
    ATXS annual earnings per share is up +30.58% year-on-year

    EPS Sector rank

    40%
    ATXS annual earnings per share is higher than 40% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    ATXS annual gross profit is $0.00

    Gross margin

    -
    ATXS annual gross profit margin value is unknown

    Operating profit

    -$111.56M
    ATXS annual operating income is -$111.56 million

    Operating margin

    -
    ATXS annual operating profit margin value is unknown

    Net income

    -$94.26M
    ATXS annual net profit is -$94.26 million

    Net margin

    -
    ATXS annual net profit margin value is unknown

    Expenses

    Total expenses

    $94.26M
    ATXS annual total expenses is $94.26 million

    Operating expenses

    $111.56M
    ATXS annual total operating expenses is $111.56 million

    Cost of goods sold

    $0.00
    ATXS annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $0.00
    ATXS annual SGA is $0.00

    Depreciation and amortization

    -
    ATXS annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    ATXS annual interest expense is $0.00

    Income tax

    $0.00
    ATXS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$111.56M
    ATXS annual earnings before interest & taxes is -$111.56 million

    EBITDA

    -$111.56M
    ATXS annual EBITDA is -$111.56 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $342.36M
    ATXS annual total assets is $342.36 million

    Non current assets

    $7.72M
    ATXS annual long term assets is $7.72 million

    Current assets

    $334.64M
    ATXS annual total current assets is $334.64 million

    Cash and cash equivalents

    $328.13M
    ATXS annual cash & cash equivalents is $328.13 million

    Accounts receivable

    -
    ATXS annual accounts receivable value is unknown

    Inventory

    $0.00
    ATXS annual inventory is $0.00

    Liabilities

    Total liabilities

    $23.10M
    ATXS annual total liabilities is $23.10 million

    Long term liabilities

    $3.97M
    ATXS annual total long term liabilities is $3.97 million

    Current liabilities

    $19.13M
    ATXS annual total current liabilities is $19.13 million

    Accounts payable

    $4.32M
    ATXS annual accounts payable is $4.32 million

    Debt

    Total debt

    $5.35M
    ATXS annual total debt is $5.35 million

    Total debt 1-year change

    +1527.05%
    ATXS annual total debt is up +1527.05% year-on-year

    Long term debt

    $3.97M
    ATXS annual long term debt is $3.97 million

    Short term debt

    $1.38M
    ATXS annual short term debt is $1.38 million

    Equity & Capital

    Shareholders equity

    $319.26M
    ATXS annual stockholders equity is $319.26 million

    Book value

    $223.94M
    ATXS annual book value is $223.94 million

    Retained earnings

    -$674.79M
    ATXS annual retained earnings is -$674.79 million

    Working capital

    $315.51M
    ATXS annual working capital is $315.51 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$81.21M
    ATXS annual cash flow from operations is -$81.21 million

    Cash from operations 1-year change

    -18.65%
    ATXS annual cash flow from operations is down -18.65% year-on-year

    Cash from investing

    -$191.86M
    ATXS annual cash flow from investing activities is -$191.86 million

    Cash from investing 1-year change

    -242.07%
    ATXS annual cash flow from investing activities is down -242.07% year-on-year

    Cash from financing

    $157.20M
    ATXS annual cash flow from financing activities is $157.20 million

    Cash from financing 1-year change

    +77.83%
    ATXS annual cash flow from financing activities is up +77.83% year-on-year

    CAPEX

    CAPEX

    $325.00K
    ATXS annual capital expenditures is $325.00 thousand

    CAPEX 1-year change

    +1200%
    ATXS annual capital expenditures is up +1200% year-on-year

    Free Cash Flow

    Free cash flow

    -$81.54M
    ATXS annual free cash flow is -$81.54 million

    Free cash flow 1-year change

    -19.08%
    ATXS annual free cash flow is down -19.08% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ATXS annual gross profit margin value is unknown

    Operating margin

    -
    ATXS annual operating profit margin value is unknown

    Net margin

    -
    ATXS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -31.58%
    ATXS annual return on assets is -31.58%

    ROE

    -33.52%
    ATXS annual return on equity is -33.52%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ATXS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ATXS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.57
    ATXS price to book ratio is 2.57

    PB ratio Sector rank

    60.1%
    ATXS price to book ratio is higher than 60.1% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ATXS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ATXS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $169.98M
    ATXS enterprise value is $169.98 million

    Enterprise value Sector rank

    53.63%
    ATXS enterprise value is higher than 53.63% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.29
    ATXS EV/EBITDA is -1.29

    EV/EBITDA Sector rank

    43.87%
    ATXS EV/EBITDA is higher than 43.87% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    17.49
    ATXS annual current ratio is 17.49

    Quick ratio

    17.49
    ATXS annual quick ratio is 17.49

    Leverage

    Debt to equity

    0.02
    ATXS annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    ATXS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ATXS piotroski f-score value is unknown

    Altman Z-Score

    8.29
    ATXS altman z-score is 8.29

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 JMP Securities
    Market Outperform
    Aug 13, 25 HC Wainwright & Co.
    Buy
    Jun 13, 25 HC Wainwright & Co.
    Buy
    May 14, 25 Cantor Fitzgerald
    Overweight
    Apr 29, 25 Cantor Fitzgerald
    Overweight
    Mar 12, 25 Wedbush
    Outperform
    Mar 11, 25 HC Wainwright & Co.
    Buy
    Mar 3, 25 Citizens Capital Markets
    Market Outperform
    Feb 27, 25 HC Wainwright & Co.
    Buy
    Jan 31, 25 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with ATXS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Astria Therapeutics, Inc.?
    • Does Astria Therapeutics, Inc. pay dividends?
    • What sector is Astria Therapeutics, Inc. in?
    • What industry is Astria Therapeutics, Inc. in?
    • What country is Astria Therapeutics, Inc. based in?
    • When did Astria Therapeutics, Inc. go public?
    • Is Astria Therapeutics, Inc. in the S&P 500?
    • Is Astria Therapeutics, Inc. in the NASDAQ 100?
    • Is Astria Therapeutics, Inc. in the Dow Jones?
    • When was Astria Therapeutics, Inc.'s last earnings report?
    • When does Astria Therapeutics, Inc. report earnings?

    What is the ticker symbol for Astria Therapeutics, Inc.?

    The ticker symbol for Astria Therapeutics, Inc. is NASDAQ:ATXS

    Does Astria Therapeutics, Inc. pay dividends?

    No, Astria Therapeutics, Inc. does not pay dividends

    What sector is Astria Therapeutics, Inc. in?

    Astria Therapeutics, Inc. is in the Healthcare sector

    What industry is Astria Therapeutics, Inc. in?

    Astria Therapeutics, Inc. is in the Biotechnology industry

    What country is Astria Therapeutics, Inc. based in?

    Astria Therapeutics, Inc. is headquartered in United States

    When did Astria Therapeutics, Inc. go public?

    Astria Therapeutics, Inc.'s initial public offering (IPO) was on June 25, 2015

    Is Astria Therapeutics, Inc. in the S&P 500?

    No, Astria Therapeutics, Inc. is not included in the S&P 500 index

    Is Astria Therapeutics, Inc. in the NASDAQ 100?

    No, Astria Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Astria Therapeutics, Inc. in the Dow Jones?

    No, Astria Therapeutics, Inc. is not included in the Dow Jones index

    When was Astria Therapeutics, Inc.'s last earnings report?

    Astria Therapeutics, Inc.'s most recent earnings report was on August 12, 2025

    When does Astria Therapeutics, Inc. report earnings?

    The next expected earnings date for Astria Therapeutics, Inc. is November 14, 2025
    On this page